antisense biotech | green leiter

Jun 9, 20224 min read

Antisense Therapeutics - a purpose driven biotech with global potential

It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...

May 2, 20214 min read

Recce Pharmaceuticals Limited – A revolution in development of treating superbugs

Recce Pharmaceuticals (ASX: RCE: FSE: R9Q) is a global leader in the new generation of anti-infective therapies. The company is listed on...

Jan 8, 20212 min read

Antisense shares have increased by 60% after Sarepta results

Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...

1,000 views0 comments

Dec 30, 20205 min read

mRNA and Antisense biotech - attracting the large fund managers and defining 2020

As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...

3,801 views0 comments

Dec 9, 20203 min read

Ionis Pharmaceuticals - A force for life

RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...

Nov 26, 20202 min read

Antisense Therapeutics Limited dual-lists in Europe

An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...